Molecular mechanisms of resistance to tuberculosis;Molekularne mechanizmy odporności na gruźlicȩ

Postepy Mikrobiologii

Volumn 43, Issue 1, 2004, Pages 107-127

  Rudnicka, Wiesława ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; RECOMBINANT VACCINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BCG VACCINATION; CYTOKINE PRODUCTION; HUMAN; IMMUNOREACTIVITY; INFECTION RESISTANCE; LYSOSOME; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; PERSISTENT INFECTION; PHAGOCYTOSIS; PHAGOSOME; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS;

BACILLI; CAVIA; CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 2542464229     PISSN: 00794252     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Andersen P.: TB vaccines: progress and problems. Trends Immunol. 22, 160-166 (2001)
2. Barnes P.F., Chatterjee D., Abrams J.S., Lu S., Wang E., Yamamura M., Brennan P.J., Modlin R.L.: Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. J. Immunol. 149, 541-547 (1992)
3. Baumgart K.W., McKenzie K.R., Radford A.J., Ramshaw I., Britton W.J.: Immunogenecity and protection studies with recombinant mycobacteria and vaccinia vectors coexpressing the 18-kilo-dalton protein of Mycobacterium leprae. Infect. Immun. 64, 2274-2281 (1996)
4. Beatty W., Rhoades E., Ullrich H.J., Chatterjee D., Heuser J., Russel D.: Trafficing and release of mycobacterial lipids from infected macrophages. Traffick, 1, 235-242 (2000)
5. Behr M.A., Wilson M.A., Gill W.P., Salamon H., Schoolnik G.K., Rane S., Small P.M.: Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science, 284, 1520-1523 (1999)
6. Betts J.C.: Transcriptomics and Proteomics: Tools for the identification of novel targets and vaccine candidates for tuberculosis. IUBMB Life, 53, 239-242 (2002)
7. Biet F., Kremer L., Wolowczuk I., Delacre M., Locht C.: Mycobacterium bovis BCG producing IL-18 increases antigen-specific gamma interferon production in mice. Infect. Immun. 70, 6549-6557 (2002)
8. Biet F., Locht C., Kremer L.: Immunoregulatory functions of interleukin 18 and ist role in defence against bacterial pathogens. J. Mol. Med. 80, 147-162 (2002)
9. Bikmaeva A.R., Sibiryak S.V., Valiakhmetova D.Kh., Khusnutdinova E.K.: Polymorphism of the tumor necrosis factor a gene in patients with infiltrative tuberculosis from the Bashkortostan populations. Mol. Biol. 36, 631-633 (2002)
10. Bodnar K.A., Serbina N.V., Flynn J.L.: Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect. Immun. 69, 800-809 (2001)
11. Bonar A., Andryszkiewicz M., Chmiela M., Rudnicka W., Mackiewicz P., Krawczyk Z., Szemraj J., Różalska B.: The level of serum mannose-binding lectin (MBL) and mbl gene polymorphism in patients with tuberculosis and in healthy individuals. Centr. Eur. J. Immunol. 27 (Suppl. 1) 7, (2002)
12. Brombacher F., Kastelein R.A., Alber G.: Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. 24, 207-212 (2003)
13. Brosch R., Gordon S.V., Billault A., Garnier T., Eiglmeier K., Soravito G.K., Barrell B.G., Cole S.T.: Use of a Mycobacterium tuberculosis H37Rv bacterial artificial chromosome (BAC) library for genome mapping, sequencing, and comparative genomics. Infect. Immun. 66, 2221-2229 (1998)
14. Brosch R., Gordon S.V., Buchrieser C., Pym A.S., Garnier T., Cole S.T.: Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium bovis BCG Pasteur. Yeast, 17, 111-123 (2000)
15. Chen J.M., Alexander D.C., Behr M.A., Liu J.: Mycobacterium bovis BCG vaccines exhibit defects in alanine and serine catabolism. Infect. Immun. 71, 708-716 (2003)
16. Clemens D., Horwitz M.: The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J. Exp. Med. 184, 1349-1355 (1996)
17. Cockle P.J., Gordon S.V., Lalvani A., Buddle B.M., Hewinson R.G., Vordermeier H.M.: Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics. Infect. Immun. 70, 6996-7003 (2002)
18. Cole S., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S., Eiglmeier K., Gas S., Barry R., Tekaia F., Badcock K., Basham D., Brown D., Chillingworth T., Conor R., Davis R., Devlin K., Feltwell T., Gentles S., Hamlin N., Holroyd S., hernsby T., jagels K., Barrell B.G. et al.: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 393, 1537-544 (1988)
19. Coussens P.M., Colvin Ch.J., Wiersma K., Abouzied A., Sipkovsky S.: Gene expression profiling of peripheral blood mononuclear cells from cattle infected with Mycobacterium paratuberculosis. Infect. Immun. 70, 5494-5502 (2002)
20. Downing J.F., Pasula R., Wright J.R., Twigg H.L.D., Martin W.J.D.: Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc. Natl. Acad. Sci. USA, 92, 4848-4852 (1995)
21. Duncan K. Update anti-infective. Tuberlculosis annual update. Exp. Opin. Ther. Patents, 7, 129-133 1999
22. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C.: Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. JAMA, 282, 677-686 (1999)
23. Ernst J.D.: Macrophage receptors for Mycobacterium tuberculosis. Infec. Immun. 66, 1277-1281 (1998)
24. Ferrari G., Langen H., Naito M., Pieters J.: A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell, 97, 435-447 (1999)
25. Fomukong N.G., Dale J.W., Osborn T.W., Grange J.M.: Use of gene probes based on the insertion sequence IS 986 to differentiate between BCG vacccine strains. J. Appl. Bacteriol. 72, 126-33 (1992)
26. Förtsch D., Röllinghoff M., Stenger S.: IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J. Immunol. 165, 978-987 (2000)
27. Gold J.A., Hoshino Y., Tanaka N., Rom W.N., Raju B., Condos R., Weiden MD.: Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis. Infect. Immun. 72, 645-650 (2004)
28. Gracie JA., Robertson S.E., McInnes I.B.: Interleukin-18. J. Leukoc. Biol. 73, 213-224 (2003)
29. Groves M.J.: BCG: the past, present and future of tuberculosis vaccine. J. Pharm. Pharmacol. 49 (Suppl. 1), 7-15 (1997)
30. Hansch H.C., Smith D.A., Mielke M.E., Hahn H., Bancroft G.J., Ehlers S.: Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells. Int. Immunol. 8, 1299-1310 (1996)
31. Henderson R.A., Watkins S.C., Flynn J.L. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159, 635-643 (1997)
32. Hermann J., O'Gaora P., Gallaghar A., Thole J., Young D.: Bacterial glycoproteins: a link between glycosilation and proteolytic cleavage of a 19 kDa antigen from Mycobacterium tuberculosis. EMBO J. 15, 3547-3554 (1996)
33. Hess J., Miko D., Catic A., Lehmensiek V., Russell D.G., Kaufmann S.H.: Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes. Proc. Natl. Acad. Sci. USA, 95, 5299-5304 (1998)
34. Holscher C., Atkinson R.A., Arendse B., Brown N., Myburgh E., Alber G., Brombacher F.: A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167, 6957-6966 (2001)
35. Horwitz M.A., Harth G.: A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infet. Immun. 71, 1672-1679 (2003)
36. Hou J.Y., Graham J.E., Clark-Curtiss J.E.: Mycobacterium avium genes expressed during growth in human macrophages detected by selective capture of transcribed sequences (SCOTS). Infect. Immun. 70, 3714-3726 (2002)
37. Jiao X., Lo-Man R., Guermonprez P., Fiette L., Deriaud E., Burgaud S., Gicquel B., Winter N., Leclerc C.: Dendritic cells are host cells for Mycobacteria in vivo that trigger innate and acquired immunity. J. Immunol. 168, 1294-1301 (2002)
38. th European Immunology Meeting, Intern. Proc. Div. Red. Monduzzi, 479-484 (2001)
39. Kaufmann S.H.E.: A personal view on the development of novel vaccines against tuberculosis. Nova Acta Leopoldina NF, 80, 247-258 (1999)
40. Li H., Ulstrup J.C., Jonassen T.O., Melby K., Nagai S., Harboe M.: Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG. Infect. Immun. 61, 1730-1734 (1993)
41. Mahairas G.G., Sabo P.J., Hickey M.J., Singh D.C., Stover C.K.: Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178, 1274-1282 (1996)
42. Malik Z.A., Shankar S.I., Kusner D.J.: Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction: contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages. J. Immunol. 166, 3392-3401 (2001)
43. Minnikin D.E., Minnikin S.M., Dobson G., Goodfellow M., Portaels F., van den Breen L., Sesardic D.: Mycolic acid patterns of four vaccine strains of Mycobacterium bovis BCG. J. Gen. Microbiol. 129, 889-891 (1983)
44. Miura K., Nagai S., Kinomoto M., Haga S., Tokunaga T. Comparative studies with various substrains of Mycobacterium bovis BCG on the production of an antigen protein, MPB70. Infect. Immun. 39, 540-545 (1983)
45. Mogga S.J., Mustafa T., Sviland L., Nilsen R.: Increased Bcl-2 and reduced Bax expression in infected macrophages in slowly progressive primary murine Mycobacterium tuberculosis infection. Scand. J. Immunol. 56, 383-391 (2002)
46. Moody D.B., Guy M.R., Grant E., Cheng T.Y., Brenner M.B., Besra G.S., Porcelli S.A.: CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J. Exp. Med. 192, 965-976 (2000)
47. Morris S., Kelley C., Howard A., Li Z., Collins F.: The immunogenity of single and combination vaccine against tuberculosis. Vaccine, 18, 2155-2163 (2000)
48. Morsczek C., Berger S., Plum G.: The macrophage-induced gene (mig) of Mycobacterium avium encodes a medium chain acyl-coenzyme A synthetase. Biochem. Biophys. Acta, 1521, 59-65 (2001)
49. Mustafa A.S.: Development of new vaccines and diagnostic reagents against tuberculosis. Mol. Immunol. 39, 113-119 (2002)
50. Mustafa T., Bjune G., Jonsson R., Hernandez Pando R., Nilsen R.: Increased expression of Fas ligand in human tuberculosis and leprosy lesions: a potential novel mechanism of immune evasion in mycobacterial infection. Scand. J. Immunol. 54, 630-639 (2001)
51. Neyrolles O., Gouldt K., Gares M.-P., Brett S., Janssen R., O'Gaora P., Hermann J.-L., Prevost M.-Ch., Perret E., Thole J.E.R., Young D.: Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria. J. Immunol. 166, 447-455 (2001)
52. Ohara N., Matsuoka M., Nomaguchi H., Naito M., Yamada T.: Inhibition of multiplication of Mycobacterium laepre in mouse foot pads by recombinant Bacillus Calmette-Guérin (BCG). Vaccine, 18, 1294-1297 (2000)
53. Paziak-Domańska B., Bonar B., Kowalewicz-Kulbat M., Klink M., Kowalski M., Karhukorpi, Karttunen R., Jurkiewicz M., Różalska B., Rudnicka W.: The lack of relationship between serum content of MBL, sCD14, anti-PPD and anti-Hsp65 IgG and ingestion of Mycobacterium bovis BCG bacilli by phagocytes. Arch. Immunol. Ther. Exp. 50, 337-344 (2002)
54. Peteroy-Kelly M.A., Venketaraman V., Talaue M., Seth A., Connel N.D.: Modulation of J774.1 macrophage L-arginine metabolism by intracellular Mycobacterium bovis BCG. Infect. Immun. 71, 1011-1015 (2003)
55. Phillip W.J., Nair S., Guglielmi G., Lagranderie M., Gicquel B., Cole S.T.: Physical mapping of Mycobacterium bovis BCG Pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis. Microbiology, 142, 3135-3145 (1996)
56. Pieters J., Gatfield J.: Hijacking the host: survival of pathogenic mycobacteria inside macrophages. Trends Microbiol. 10, 142-146 (2002)
57. Plum G., Clark-Curtiss J.E.: Induction of Mycobacterium avium gene expression following phagocytosis by human macrophages. Infect. Immun. 62, 476-483 (1994)
58. Poquet Y., Halary F., Champagne E., Davodeau F., Gougeon M.L., Bonneville M., Fournie J.J.: Human g/d T cells in tuberculosis. Res. Immunol. 147, 542-549 (1996)
59. Prigozy T.I., Sieling P.A., Clemens D., Stewart P.L., Behar. S.M., Porcelli S.A., Brenner M.B., Modlin R.L., Kronenberg M.: The mannose receptor delivers lipoglycan antigens to endososmes for presentation to T cells by CD1b molecules. Immunity, 6, 187-197 (1997)
60. 3 on human monocytes and monocyte-derived macrophages. Infect. Immun. 61, 663-670 (1993)
61. Reiling N., Holscher Ch., Fehrenbach A., Kroger S., Kirschning C.J., Goyert S., Ehlers S.: Cutting edge: Toll-like receptor (TLR)2- and TLR4- mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol. 169, 3480-3484 (2002)
62. Reiling N., Klug K., Krallmann-Wenzel U., Laves R., Goyert S., Taylor M.E., Lindhorst T.K., Ehlers S.: Complex encounters at the macrophage-Mycobacterium interface: Studies on the role of the mannose receptor and CD14 in experimental infection models with Mycobacterium avium. Immunobiol. 204, 558-571 (2001)
63. Rudnicka W., Brzychcy M., Klink M., Gomez Lopez A., Fonteyne P.A., Rusch-Gerdes S., Różalska B.: The production of nitric oxide and tumor necrosis factor by murine macrophages infected with mycobacterial strains differing by hemolytic activity. Microbiol. Immunol. 43, 637-644 (1999)
64. Russel D., Dant J., Sturgill-Koszycki S.: Mycobacterium avium- and Mycobacterium tuberculosis- containing vacuoles are dynamic, fusion- competent vesicles that are accessible to glycosphingolipids from the host cell plasmalemma. J. Immunol. 156, 4764-4773 (1996)
65. Schaible U.E., Winau F., Sieling P.A., Fischer K., Collins H.L., Hagens K., Modlin R.L., Brinkmann V., Kaufmann S.H. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nature Med. 8, 1039-1046 (2003)
66. Schlesinger, L.S: Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150, 2920-2930 (1993)
67. Schorey J.S., Carroll M.C., Brown E.J.: A macrophage invasion mechanism of pathogenic mycobacteria. Science, 277, 1091-1093 (1997)
68. Selvaraj P., Narayanan P.R., Reetha A.M.: Association of functional mutant homozygotes of the mannose binding protein gene with susceptibility to pulmonary tuberculosis in India. Tuber. Lung Dis. 79, 221-227 (1999)
69. Strohmeier G.S., Fenton M.J.: Roles of lipoarabinomannan in the pathogenesis of tuberculosis. Microb. Infect. 1, 709-717 (1999)
70. Sturgill-Koszycki S., Schlesinger P.H., Chakraborty P., Haddix P.L., Collins H.L., Fok A.K., Allen R.D., Gluck S.L., Heuser J., Russell D.G.: Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science, 263, 678-681 (1994)
71. Sugawara I., Yamada H., Mizuno S., Iwakura Y.: IL-4 is required for defense against mycobacterial infection. Microbiol. Immunol. 44, 971-979 (2000)
72. Sugita M., Grant E.P., Van Donselaar E., Hsu V.W., Rogers R.A., Peters P.J., Brenner M.B.: Separate pathways for antigen presentation by CD1 molecules. Immunity, 11, 743-752 (1999)
73. Tailleux L., Maeda N., Nigou J., Gicquel B., Neyrolles O. How is the phagocyte lectin keyboard played? Master class lesson by Mycobacterium tuberculosis. Trends Microbiol. 11, 259-263 (2003)
74. Tailleux L., Schwartz O., Hermann J.-L., Pivert E., Jackson M., Amara A., Legres L., Dreher D., Nicod L.P., Gluckman J.C., Lagrange P.H., Gicquel B., Neyrolles O.: DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 197, 121-127 (2003)
75. Teitelbaum R., Cammer M., Maitland M., Freitag N.E., Condeelis J., Bloom B.R.: Mycobacterial infection of macrophages results in membrane-permeable phagosomes. Proc. Natl. Acad. Sci. USA, 96, 15190-15195 (1999)
76. Thielen H., Heykes-Uden H., Niemann S.: Spread of a drug-resistant strain of mycobacterium tuberculosis among homeless people in a german city. Pneumologie, 58, 17-22 (2004)
77. Tominaga K., Yoshimoto T., Torigoe K., Kurimoto M., Matsui K., Hada T., Okamura H., Nakanishi K.: IL-12 synergizes with IL-18 or IL-1β for IFN-γ production from human T cells. Intern. Immunol. 12, 151-160 (2000)
78. Underhill D.M., Ozinsky A., Smith K.D., Aderem A. Toll-like receptor 2 mediates mycobacteria induced proinflammatory signaling in macrophages. Immunity, 96, 14459-14463 (1999)
79. Von Reyn C.F., Arbeit RD., Yeaman G., Waddell R.D., Marsh B.J., Morin P., Modlin J.F., Remold H.G.: Immunization of healthy adult subjects in the United States with inactivated Mycobacterium vaccae administered in a three-dose series. Clin. Infect. Dis. 24, 843-848 (1997)
80. Xu D., Chan WL., Leung BP., Hunter D., Schultz K., Carter RW, McInnes IB., Robinson JH.: Selective expression and functions of intereleukin 18 receptor on T helper (Th) type 1 but not Th2 Cells. J. Exp. Med. 188, 1485-1492 (1988)